Introduction {#s1}
============

Angiogenesis is the process by which pre-existent vessels rearrange in order to give rise to new vascular beds ([@b33]). The mouse retina is one of the best characterized models for *in vivo* vessel formation as it displays all of the morphological hallmarks of angiogenesis (i.e. sprouting, branching, fusion, remodelling and maturation) after birth ([@b19], [@b20]). In contrast to human, murine newborns do not possess a developed retinal vascular plexus ([@b24]). In these, the superficial retinal vascular plexus forms during the first week after birth by radial outgrowth of vessels from the optic nerve entry point to the periphery ([@b20]; [@b56]). These superficial vessels reach the retinal edges at approximately post-natal day (P) 9 and from this stage onwards, vertical sprouting forms the deep and then intermediate vascular beds, that reach the retinal periphery at approximately P12 and P15, respectively. The three retina vascular beds become fully mature and interconnected at the end of the third postnatal week ([@b56]). At this stage, the retinal superficial vasculature is composed of six major arteries and veins that form primary branches into arterioles and venules. Arterioles and venules branch into a capillary network that is in direct contact with deep and intermediate layers. This network is covered with pericytes, providing retina with the densest coverage of pericytes in the whole vasculature ([@b53]). The choroidal vascular system, which resides between the retina and the sclera, is fully developed before birth and supplies oxygen and nutrients to the avascular retina ([@b14]). At early stages, the blood supply of the eye is also provided by the hyaloid vasculature that originates from the central hyaloid artery in the optic nerve and extends through the primitive vitreous toward the anterior segment ([@b50]). The hyaloid vasculature regresses when ocular development proceeds in order to leave a transparent visual axis ([@b40]; [@b13]).

Blood vessels are mainly composed of an inner endothelial cell (EC) layer externally covered by mural cells, namely vascular smooth muscle cells (VSMCs) in arteries and veins, and pericytes in capillaries ([@b33]). In the mature vascular plexus, mural cells contribute to endothelial tube stabilization, maintenance of vascular permeability and regulation of the blood flow. In small arterioles and capillaries, most of these activities are performed by pericytes ([@b44]; [@b51]; [@b17]; [@b3]). In the central nervous system, not all the pericytes contain the muscle-specific actin isoform, only those in the pre- and postcapillary regions (i.e. on arterioles and venules) ([@b42]; [@b49]). This led to the proposition that blood flow is regulated mainly at the level of precapillary arterioles ([@b1]; [@b5]). However, time-lapse and functional analyses have demonstrated that capillaries are capable of regulating blood flow along their whole length ([@b39]; [@b47]). In the eye, vasoconstriction and vasodilatation via the pericytes are evoked by light-induced stimulation of perivascular astrocytes ([@b39]).

Msx genes encode homeodomain transcription factors and are essential for normal craniofacial and limb development, nervous system patterning, eye formation, as assessed by phenotypic abnormalities in knock-out mice ([@b4]; [@b62]; [@b32]; [@b35], [@b36]). In the cardiovascular system, Msx genes have previously been shown to be important for outflow tract patterning ([@b32]; [@b16]), head vessel maturation ([@b37]) and adult vessel calcification ([@b58]). In adult mice, *Msx2^lacZ^* is mainly expressed in a subset of VSMCs in peripheral arteries and veins (brachial, femoral and caudal), as well as a few ECs of the aorta. *Mxs1^lacZ^* is expressed to a lesser extent by VSMCs of peripheral arterial trunks, but is highly expressed in mural cells of arterioles and capillaries that irrigate the tissues ([@b23]).

In this paper, we observe that *Msx2^lacZ^* expression is not detectable in eye vessels, and describe *Msx1* expression patterns in the retina and choroid vasculature. In the choroid, *Msx1^lacZ^* is expressed in a broad dynamic pattern, initially in the endothelium. Expression is observed later on in VSMCs, similar to *Msx1* general behaviour in the peripheral vasculature. In contrast, in the retina, *Msx1^lacZ^* expression is restricted to ECs of the arteriolar branching points in the superficial vascular network. At these branch points, we further characterised a sub-population of pericytes, which express high levels of NG2, α-SMA and desmin. We thus demonstrate specific properties of cells constituting these branching structures, not only in the mural layer but also in the endothelial layer.

Results {#s2}
=======

Kinetics of *Msx1*^lacZ^ expression in vessels of the developing retina {#s2a}
-----------------------------------------------------------------------

Outgrowth of vessels in the retina occurs postnatally from the central optical disc. This results in the formation of a stereotyped vascular network ([@b20]). Analysis of *Msx1^lacZ^* mice at P0 revealed that the primitive plexus was formed of ECs and did neither express smooth muscle actin, nor *Msx1* ([Fig. 1A,A′](#f01){ref-type="fig"}, arrowheads). The hyaloid vasculature, which is present during prenatal development and regresses shortly after birth, expressed strong levels of *Msx1^lacZ^* as revealed by Xgal staining, and was covered with α-SMA-expressing mural cells ([Fig. 1A,A′](#f01){ref-type="fig"}, arrows). Considering the morphology of the β-galactosidase (β-gal)-positive nuclei and their position relative to isolectin B4 (Ib4) and α-SMA domains, *Msx1*-expressing cells were likely ECs. At P3, retinal arteries have started to form from the primitive plexus. These arteries, which were part of the newly-formed vascular plexus ([Fig. 1B′](#f01){ref-type="fig"}; data not shown), were covered with α-SMA-positive mural cells. In these arteries, *Msx1* expression was detected in cells with elongated nuclei, suggesting they belonged to the endothelium ([Fig. 1B,B′](#f01){ref-type="fig"}, arrows). At this stage, no *Msx1* expression could be detected in less mature vessels not covered by mural cells ([Fig. 1B,B′](#f01){ref-type="fig"}, arrowheads). At P10, the superficial vessels have reached the peripheral edge of the retina, the capillary bed has begun to develop into the deeper layers and circulation has started ([@b13]; [@b20]). Strikingly, at this stage *Msx1^lacZ^* expression became restricted to primary branching points in arterioles ([Fig. 1C,C′](#f01){ref-type="fig"}, arrows). Restricted expression was not yet completed by P12, since a few cells were still expressing *Msx1* along the length of arteries ([Fig. 2A](#f02){ref-type="fig"}, arrowheads), but was achieved at P14 ([Fig. 1D,D′](#f01){ref-type="fig"}). In most cases, more than one nucleus was labelled ([Fig. 1F](#f01){ref-type="fig"}, [Fig. 3D-F](#f03){ref-type="fig"}, [Fig. 4A,C](#f04){ref-type="fig"}). At the branching points, we further observed strong Ib4 concentration that co-localized with *Msx1*-expressing cells ([Fig. 1C′-F′](#f01){ref-type="fig"}, arrows). Ib4 is known to bind the basement membranes (specifically, the versican protein) and thus can label not only ECs but also microglial cells and probably other cell types including some vascular mural cells. On trypsin-digested retinas, Ib4 was unambiguously associated with vessels (not shown). Maximum *Msx1* expression occurred between P14 and P23 ([Fig. 1D--E](#f01){ref-type="fig"}), but expression was maintained at high levels up to P480 ([Fig. 1F](#f01){ref-type="fig"}) and probably lasts over the lifetime of the animal. From P14, we observed that *Msx1* also labelled secondary branches in the arteriolar network ([Fig. 1F](#f01){ref-type="fig"}, [Fig. 4D](#f04){ref-type="fig"}). Noticeably, at all stages, *Msx1* expression was observed only in rather mature arteries that were covered by a SMA-positive mural cell coating suggesting that *Msx1* expression in the endothelium requires EC-VSMC interactions. *Msx1*-labelled branching sites were quantitated throughout development ([Fig. 2](#f02){ref-type="fig"}). There was a large and steady increase between P9 and P23 and thereafter the number plateaued. Therefore, restriction of the expression to branching sites lagged behind the formation of the vascular superficial bed, for which arteries reach the retinal periphery around P8 ([@b20]). This was not achieved before the onset of blood flow, which in the mouse retina takes place between P3 and P4 ([@b13]). From P23, we observed *Msx1* expression at all primary, and some secondary, branching points along the main retinal arteries.

![Kinetics of *Msx1^lacZ^* expression in the retina.\
Flat-mount retinas from P0, P3, P10, P14, P23 and P480 *Msx1^nlacZ+/−^* mice were analysed. (A--F) show light microscopy views in which Xgal staining (blue, arrows) labels the nucleus of *Msx1*-expressing cells. (A′--F′) show the corresponding fluorescence fields for ECs (IB4, green) and mural cells (α-SMA, red). At P0 (A, A′), the superficial plexus that is just beginning to develop around the optic nerve does not express *Msx1^lacZ^* (arrowheads). At the same stage the hyaloid vessels are covered with α-SMA-positive cells and are labelled with Xgal (arrows). At P3 (B, B′), *Msx1^lacZ^* is expressed in elongated nuclei along the first formed retinal arteries (arrows) that are covered with α-SMA-positive cells. Note that these arteries are in continuity with the vascular immature, endothelial plexus that does not express *Msx1^lacZ^* (arrowheads). Around P10 (C, C′), Xgal staining starts to concentrate at the primary branching sites of the superficial retinal arteries (arrows). Note that some branching sites express *Msx1* very weakly at this stage (arrowheads). Expression is observed in all primary branch points at later stages, such as P23 (E, E′) and P480 (F, F′), and even at some secondary branches (F, F′). Xgal staining was most intense between P14 and P23 (D, E). In all panels, scale bar  = 50 µm.](bio-01-04-376-f01){#f01}

![Quantification of *Msx1*-expressing branching sites during retinal vessel development.\
At P12 (A), some expression is still observed along the vessels (arrowheads) in addition to branch sites (arrows). From P23 to P480 (B,C), expression is restricted to branch sites (arrows). In A--C, artery layout is depicted for legibility. (D) shows the total number of branch points along a single main artery that express *Msx1* at each stage analysed. At P0 and P3, no *Msx1*-positive branching points were observed. They then increased significantly in number from P9 to P23. From this stage, this number remained stable. n = 6, (\*) *P*\<0.05, (\*\*) *P*\<0.01, (\*\*\*) *P*\<0.001. In panels A--C, scale bar  = 50 µm.](bio-01-04-376-f02){#f02}

![*Msx1^lacZ^* is expressed specifically in the endothelial layer.\
Confocal images of flat mount retinas from P21 mice, stained for (A,C,D,F) mural (α-SMA, red) or (B--F) endothelial (CD31, green) markers and β-gal (A--F, yellow). At branching sites, the β-gal signal is nuclear and is completely restricted to CD31-positive cells (B,E, arrowheads), which are themselves ensheathed in the α-SMA-positive cell layer (A,D, arrows). This is particularly obvious in merged images (C,F), demonstrating that β-gal-expressing cells are endothelial cells. In all panels, scale bar  = 20 µm.](bio-01-04-376-f03){#f03}

![Characterization of the *Msx1*-expressing branching points.\
Flat-mount retinas from P14 *Msx1^lacZ^* mice were stained with Xgal (A--D) in combination with antibodies against α-SMA (A′, red), desmin (B′, red), the pericyte marker NG2 (C′, green), or the basal lamina protein laminin (D′, green). α-SMA labels VSMCs and a population of pericytes that are concentrated at the beginning of the primary branches (A,A′, arrows). Most of the mural cells observed at the major branching points also express desmin (B′) and NG2 (C′). Laminin signal is strongest in the major arterioles and at the beginning on the primary branches (D′). The vast majority of primary, and some secondary, branches do express *Msx1^lacZ^* (D,D′). *Msx1^lacZ^*-positive cells adopt a luminal localization relatively to the mural markers. In all panels, scale bar  = 50 µm.](bio-01-04-376-f04){#f04}

Arteries and veins were identified in flat mounts by virtue of their distinct morphologies and differential coating by mural cells. We did not observe *Msx1^lacZ^* labelling of venules in the retina (data not shown), as in any other veins ([@b23]). Only the superficial vascular network was labelled. This is in keeping with the fact that deeper beds are primarily formed by sprouting from veins ([@b20]). Xgal staining reflected the specific expression of *Msx1* in retinal vessels since no staining was observed in normal mice (data not shown). In contrast to what was observed in peripheral arteries ([@b23]), *Msx2^lacZ^* could not be detected in hyaloid, retina or choroid vessels at any stage of their development (data not shown).

*Msx1^lacZ^* is expressed specifically in ECs {#s2b}
---------------------------------------------

Xgal staining is useful for a broad analysis of expression patterns. However, it does not provide sufficiently high resolution for precise co-localization studies using optical microscopy. In order to identify in which cell type *Msx1^lacZ^* is expressed, we used an anti β-gal antibody together with endothelial-specific (anti-CD31) and mural-specific (anti-α-SMA) antibodies, to perform confocal microscopy on flat mount retinas. This showed that the *Msx1* reporter gene is expressed in ECs ([Fig. 3B,E](#f03){ref-type="fig"}, arrowheads) and not in mural cells ([Fig. 3A,D](#f03){ref-type="fig"}, arrows). Indeed, the nuclear β-gal signal was completely surrounded by CD31 protein and was observed in a luminal position relative to the mural marker α-SMA ([Fig. 3C,F](#f03){ref-type="fig"}). As expected, β-gal colocalized with nuclear Hoechst staining, since the *lacZ* gene in this transgenic mouse is associated with a nuclear localisation sequence (not shown).

Correlation between expression of *Msx1* and branch point-characteristic proteins {#s2c}
---------------------------------------------------------------------------------

To get insight into the role of *Msx1* at arteriolar branching points, we investigated possible correlations with accumulation of other proteins. We co-stained the retina from *Msx1^lacZ^* animals for β-gal together with α-SMA ([Fig. 4A,A′](#f04){ref-type="fig"}), desmin ([Fig. 4B,B′](#f04){ref-type="fig"}) and NG2 ([Fig. 4C,C′](#f04){ref-type="fig"}). In the rat retina, NG2 and desmin are expressed in immature mural cells around birth, but NG2 is expressed in pericytes in the adult and weakly in arteriole and vein VSMCs, whereas desmin remains at a high level in pericytes and VSMCs. On the contrary, α-SMA, which is also expressed in immature mural cells, becomes highly expressed in VSMCs and weakly in pericytes after birth ([@b29]). According to our data, the primary branching structures were supported by a sub-population of mural cells that expressed α-SMA ([Fig. 4A′](#f04){ref-type="fig"}), desmin ([Fig. 4B](#f04){ref-type="fig"}′) and NG2 ([Fig. 4C′](#f04){ref-type="fig"}). Of note, calponin is expressed primarily in VSMCs, although it has been described in pericytes of aged animals ([@b29]; [@b30]). Calponin was expressed in a fraction of branching structures, and always in cells on the distal side relative to the arteriole (not shown). Thus, at the branch sites, the sub-population of mural cells differs from others by its capacity to express simultaneously VSMC-associated proteins, such as α-SMA and calponin, together with pericyte markers like NG2 and desmin. Of note, α-SMA, desmin and calponin are proteins that participate in contraction, making this structure a candidate for specific contractile properties. Furthermore, according to Ib4 ([Fig. 1C′--F′](#f01){ref-type="fig"}) and laminin ([Fig. 4D′](#f04){ref-type="fig"}, arrows) expression levels, the density of the basement membrane at these branching points appeared high.

No apparent developmental defect in *Msx1*^flox/\ flox^ *Msx2*^flox/\ flox^ Tie2Cre mutant {#s2d}
------------------------------------------------------------------------------------------

To further investigate the possible function of Msx genes in the retinal endothelium, we inactivated *Msx1* and *Msx2* specifically in ECs, taking advantage of the previously described *Msx1^flox^* ([@b21]) and *Msx2^flox^* ([@b9]) alleles, and the *Tie2-Cre* transgene ([@b34]). Only *Msx1* is expressed in the retina; however *Msx2* was also inactivated to avoid any compensation between the two genes ([@b32]; [@b37]).

Tie2-Cre has been shown to specifically induce loxP site recombination in the retina EC plexus ([@b64]; [@b60]; [@b57]). However, no data has been reported referring to the efficiency of this transgene in ECs at branching site. To ascertain this point, we associated the Rosa^mT/mG^ reporter gene ([@b41]), that expresses *Tomato* red before and *Gfp* after loxP recombination, with the *Tie2-Cre* transgene. GFP was revealed on dissected retinas using specific anti-GFP antibodies, together with antibodies against endothelial (CD31) or mural (α-SMA) markers. This demonstrated recombination in all ECs, including those residing at branching sites (supplementary material Fig. S1).

These data allowed us to perform the functional analysis. Dissected retinas from *Msx1^flox/+^ Msx2*^flox/+^ Tie2-Cre\</emph\> and *Msx1^flox/\ flox^ Msx2^flox/\ flox^ Tie2-Cre* mice were labelled for CD31, *α*-SMA and desmin, then analysed in flat mount by confocal microscopy. *Msx1* and *Msx2* inactivation in the endothelium did not result in major structural defects, neither at P7, when the vessels are intensely sprouting ([Fig. 5A-F](#f05){ref-type="fig"}), nor in two months-old animals, when angiogenesis is achieved ([Fig. 5G--L](#f05){ref-type="fig"}). At the two stages, CD31 staining ([Fig. 5A,D, C,F and G--J](#f05){ref-type="fig"}) did not reveal either over- or under-branching in arteries, where *Msx1^lacZ^* is expressed. Furthermore, considering the intensity of α-SMA ([Fig. 5B,E and H,K](#f05){ref-type="fig"}) and desmin ([Fig. 5I,L](#f05){ref-type="fig"}) signals, there was no conspicuous reduction in VSMC coverage or decrease in the expression of contractile proteins at branching sites. In the retina, desmin is strongly expressed in pericytes ([@b29]), and we could not detect any difference in the number of desmin-positive cells in capillaries of mutant versus control embryos ([Fig. 5I,L](#f05){ref-type="fig"}).

![There is no evident phenotypic alterations in the *Msx1^flox/\ flox^ Msx2^flox/\ flox^ Tie2-Cre* mouse retinas.\
Retinas from heterozygous (A--C) or mutant (D--F) P7 mice were stained for CD31 (green, A,D,C,F), α-SMA (red, B,E); similarly, retinas from 2 months old mice were stained for CD31 (green, G,J), α-SMA (red, H,K) and desmin (red, I,L). At P7, the overall structure of retina vasculature does not look changed (A,D) in mutants. Close up images of the angiogenic front do not show differences in vascular density or in the morphological characteristics and number of tip cells (C,F). At this stage, only the main arterial branches are covered by VSMCs in both the mutant (E) and the control (B). In retinas from 2 month-old mice, the density of branches along the endothelial tube appears unchanged in the mutant according to CD31 staining (G,J). The intensity and number of cells expressing α-SMA is similar between the *Msx1^flox/\ flox^ Msx2^flox/\ flox^ Tie2-Cre* mutant (K) and the *Msx1^flox/+^ Msx2^flox/+^ Tie2-Cre* control (H). The desmin-positive population of pericytes does not look affected by the endothelial-specific Msx gene inactivation (I,L). Note that, in D, the centre of the retina was accidentally lost during dissection. In panels A,B and D,E, scale bar is 400 µm, in panels G,H and J,K, 40 µm, in panels C, F and I, 100 µm and in panel L, 50 µm, respectively.](bio-01-04-376-f05){#f05}

*Msx1* is broadly expressed in choroid vessels {#s2e}
----------------------------------------------

To verify whether this branch site-restricted expression pattern is more widespread in the eye vasculature, we investigated *Msx1* expression in the choroid. In the mouse, choroidal vasculature is fully developed before birth and supplies oxygen and nutrients to the anterior region of the retina ([@b14]). Similar to the retinal vasculature, it develops according to a stereotyped pattern, constituted of major arteries that grow from the optic nerve entry point toward the periphery. *Msx1^lacZ^* expression was detectable as early E16.5 and became conspicuous at E17.5. At these stages, expression took place in arterioles covered with *α*-SMA-expressing mural cells and also in mural cell-free capillaries (data not shown). At P0, *Msx1^lacZ^* was broadly expressed in choroidal vessels, at a high level ([Fig. 6A,A′](#f06){ref-type="fig"}). On flat mounts, expression was observed in internal, longitudinal cells, which matched Ib4 labelling, suggesting it took place in ECs. Similar to prenatal stages, expression was observed in mural cell-covered ([Fig. 6A,A′](#f06){ref-type="fig"}, arrows) as well as mural cell-free ([Fig. 6A,A′](#f06){ref-type="fig"}, arrowheads) arteries. Surprisingly, at P14 and later, *Msx1^lacZ^* expression was detected in cells resembling mural cells, since the β-gal-positive nuclei exhibited a rounder shape and a more external position ([Fig. 6B,B′](#f06){ref-type="fig"}). Furthermore, expression was now restricted to mural cells-covered arteries. We analysed *Msx1^lacZ^* expression until P150 and the location and intensity of Xgal staining did not change with age ([Fig. 6C,C′](#f06){ref-type="fig"}).

![Kinetics of *Msx1^lacZ^* expression in the mouse choroid.\
Flat-mounted choroids at P0, P14 and P150 were stained with Xgal (blue), anti-α-SMA antibody (red) and Ib4 (green), demonstrating a broad expression of *Msx1^lacZ^*in choroidal vessels. At P0 (A,A′), *Msx1*-expressing cells seem to be in a luminal position relative to α-SMA and to coincide with Ib4 labelling. At this stage, they are observed in vessels either covered with α-SMA-positive cells (arrows) or not (arrowheads). At P14 (B,B′), *Msx1^lacZ^* expression is still strong in the arterioles and major capillaries, but the β-gal-positive nuclei look rounder and their position appears more to the exterior. At P150 (C,C′), this pattern of expression in maintained. In all panels, scale bar  = 50 µm.](bio-01-04-376-f06){#f06}

To confirm the shift in expression of *Msx1^lacZ^* from endothelial to mural cells, we performed a confocal analysis of choroid transverse sections. At P0, the nuclear β-gal protein was observed in most CD31-positive cells of the major arterioles ([Fig. 7A](#f07){ref-type="fig"}, arrows). Clearly, *α*-SMA-positive cells did not accumulate β-gal protein ([Fig. 7B](#f07){ref-type="fig"}, arrowheads). At P21 the localization of β-gal had changed dramatically: CD31-surrounded nuclei appeared completely devoid of β-gal protein ([Fig. 7C](#f07){ref-type="fig"}, arrows) whereas α-SMA-positive cells expressed high levels of this protein ([Fig. 7D](#f07){ref-type="fig"}, arrowheads). This change in pattern was observed in the whole choroid vascular tree as shown in [Fig. 6](#f06){ref-type="fig"}.

![Dynamic expression of *Msx1^lacZ^* in the choroidal vessels.\
Immunofluorescence was performed on transverse sections of mouse choroids. VSMCs were labelled for α-SMA (red), ECs for CD31 (green) and *Msx1^lacZ^* expression was revealed using anti-β-gal antibodies (yellow). At P0, the β-gal protein can be observed in CD31-expressing endothelial cells (A, arrows), α-SMA expressing cells are completely negative for β-gal (B, arrowheads). At P21, the endothelial CD31-positive cells do not contain β-gal (C, arrows), in contrast to VSMCs that are strongly labelled for β-gal (D, arrowheads). These results reflect an EC-to-VSMC shift of *Msx1^lacZ^* expression during the first three weeks after birth. In all panels, scale bar  = 10 µm.](bio-01-04-376-f07){#f07}

Discussion {#s3}
==========

Studying the different structures that compose the retina and choroid vasculature may give insight into disease processes such as diabetic or hypertensive retinopathy, hypertensive choroidopathy and macular degeneration. Taking advantage of *Msx1^lacZ^* and *Msx2^lacZ^* knock-in mice, we have established that *Msx1*, but not *Msx2*, is expressed in the mouse retinal and choroidal vasculature. One of the most striking results we obtained is the specific expression of *Msx1* in a cluster of ECs at primary, and sometimes secondary, arteriolar branching sites in the retina. This property might be more widespread in the peripheral vasculature. We previously reported that *Msx1* expression is more intense in arterioles of the thigh muscle at branching sites ([@b23]). Our data suggested that expression took place in VSMCs, but the situation should be revisited using confocal microscopy at these sites. The expression pattern we observe in retina raises questions about the function *Msx1* may play and the mechanisms that might activate it at branching sites.

*Msx1* is unlikely to be associated with formation or stabilization of retinal arteriole branches, since disruption of the *Msx1* gene specifically in the endothelium does not lead to defects in branching frequency or branch stability. A function related to vessel physiology is therefore more likely. In any case, *Msx1* may be responding to specific signalling molecules at these sites. The Notch pathway is of particular relevance to this issue. The initial pattern of *Jag1* expression in the retina is different from that of *Msx1*, but at P15, Jag1-positive cells are concentrated at branch points in arteries, in both endothelial and mural cells, in a pattern strikingly similar to *Msx1* ([@b26]). However, *Jag1* null mice die by E11.5 as a result of a lack of vascular remodelling ([@b63]), a phenotype very different from the one observed in *Msx1* single or *Msx1*; *Msx2* double null mutant ([@b52]; [@b35]). Furthermore, Notch signalling plays a major role in controlling sprouting and at P6, in endothelium-specific *Jag1* mutants, the density of newly formed vessels at the periphery of the retina is clearly reduced ([@b7]). This phenotype was not observed in the endothelium-specific mutation of *Msx1* ([Fig. 5C,F](#f05){ref-type="fig"}). Altogether, these considerations imply that, if *Msx1* is involved in the Notch pathway, it relays only a fraction of Notch activity. *Tie1*, an endothelial-specific receptor of the Tie receptor tyrosine kinase family with unknown ligand, is also expressed in the retinal vessels, and further concentrated at branching sites ([@b48]). Other signalling pathways, not yet characterized in the retinal vasculature, may play a role in *Msx1* expression.

Conspicuously, branching sites in retinal arterioles form specific structures, which have been designated as arteriolar annuli ([@b25]; [@b54]). These are characterized by hypercellularity and specific or enhanced expression of a number of genes. Among these are *α-Sma*, *Vimentin* ([@b6]) and *Jag1* ([@b26]). Our own data confirm and extend these reports; in particular, they demonstrate that mural cells at the branching sites express *NG2*, the most characteristic marker of pericytes to date ([@b45]), and simultaneously, *α-Sma* and *calponin*, which, in mature retinal vasculature, are essentially restricted to VSMCs ([@b29]). The basement membrane, which is formed by a synergistic process between endothelial and mural cells, is also modified at *Msx1*-expressing bifurcation points. A higher density of basement membrane proteins such as versican (which was detected by Ib4) and laminin is observed. Noticeably, *Msx1* does not seem to play a role in endothelial secretion of basement membrane proteins since Ib4 and laminin staining in *Msx1^flox/\ flox^ Msx2^flox/\ flox^ Tie2Cre* retinas is completely normal (data not shown). Altogether, our data show that, in addition to mural cells, ECs at branching sites also exhibit specific expression programs as assessed by *Msx1* expression.

Hyperaemia (i.e. the increase in blood perfusion associated with neural activity), which is at the basis of functional neuroimaging ([@b38]), implies mechanisms to regulate blood flow. These have been proposed to take place at the precapillary level in the arteriole ([@b1]). However, the existence of a precapillary sphincter in the retina at the junction between arterioles and capillaries is controversial, has been poorly documented in recent years and the sphincter itself not always rigorously defined ([@b18]; [@b1]; [@b61]; [@b5]). From structural analyses, some investigators reported its existence ([@b8]; [@b31]), while other could not detect it ([@b46]). Furthermore, theoretical and experimental studies have shown that regulation of blood flow at the precapillary level is unlikely to play a major role in the capillary filtration coefficient ([@b10]; [@b11]). Functional analyses indicate that flow regulation takes place over the whole capillary network, via a coupling between astrocytes and blood vessels ([@b66]; [@b15]; [@b39]; [@b47]). However, a more recent functional study, based on laser speckle flowmetry, suggests that in the retina, activity-dependent changes in blood flow are controlled largely by arterioles and that capillaries contribute little to them, without documenting specific structures responsible for this control ([@b55]). *Msx1* expression in the retina is restricted to primary and secondary branching sites between arteries and arterioles. At these sites, contraction-associated proteins are concentrated, and it is plausible that *Msx1* may play a role at the arteriolar level in controlling blood flow.

Arteriolar annuli, and also *Msx1* expression, could be linked to mechanical constraints at branching sites. Vascular bifurcations are associated with local modifications in rate and pattern of blood flow, including low wall and high oscillatory shear stress ([@b65]). Noticeably, the ECs are primarily affected by shear stress, as they are in direct contact with blood flow. Indeed, genes in the endothelium are activated in response to shear stress ([@b2]; [@b43]) via specific DNA responsive elements ([@b12]). In addition, increased hemodynamic stresses *in vivo* enhance smooth muscle cell coverage of microvessels ([@b59]). Shear stress is not negligible in retina arteries and arterioles ([@b22]), thus *Msx1* expression may be linked to blood flow at branching sites. Noticeably, restriction of *Msx1* expression at these sites correlates with the onset of blood flow in the deeper vascular beds of the retina ([@b56]), which might substantially change shear stress at bifurcations. It would be necessary to perform arterial obstructive lesions in the retina to evaluate the relation between blood flow and *Msx1* expression.

Another intriguing result that we have obtained concerns the *Msx1^lacZ^* pattern of expression in the choroid, which shifts from endothelial to mural cells in the first three weeks of life ([Fig. 7](#f07){ref-type="fig"}). Previously, we published that *Msx1* is expressed in adult mouse VSMCs and pericytes and, in the embryo, in ECs and VSMCs ([@b23]). However, we have never observed expression of *Msx1* in endothelial and mural cell populations in the same vascular bed, either simultaneously or consecutively. Both cells types are regulated by distinct mechanisms and *Msx1* has been associated with a number of different cells types in distinct developmental contexts. Therefore, we think that *Msx1* plays different and independent roles in the endothelial and mural lineages. In addition, we should stress that, after P21, the *Msx1* pattern of expression observed in the choroid is quite similar to the pattern observed in other peripheral arterioles and capillaries ([@b23]).

Materials and Methods {#s4}
=====================

Mice {#s4a}
----

Generation of *Msx1^lacZ^*, *Msx2^lacZ^* and *Msx2^flox^* mutant mice has been described previously ([@b28]; [@b35]; [@b9]). The *Msx1^flox^* conditional mutant ([@b21]) was a generous gift from Dr. Robert Maxson (Los Angeles, California, USA), the *Tie2-Cre* transgenic mouse ([@b34]), from Dr. Masashi Yanagisawa (Dallas, Texas, USA). The α-*Sm22Cre* ([@b27]) and *Rosa^mT/mG^* reporter mouse ([@b41]) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). All strains were maintained on an NMRI outbred background. Genotyping primers were previously described ([@b37]). Phenotypic analyses were conducted with mutant embryos using littermates as controls. Animals were housed in the Institut Pasteur animal facilities accredited by the French Ministry of Agriculture to perform experiments on live mice (accreditation \# B 75 15-05, issued on May 22, 2008), in appliance of the French and European regulations on care and protection of the Laboratory Animals (EC Directive 86/609, French Law 2001-486 issued on June 6, 2001). Protocols were approved by the veterinary staff of the Institut Pasteur animal facility and were performed in compliance with the NIH Animal Welfare Insurance \#A5476-01 issued on 02/07/2007.

Processing of eye tissues {#s4b}
-------------------------

Eyes were collected at postnatal days 0 to 480 (P0-P480). Eyes were enucleated and immediately fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) pH 7.2 (Sigma) for 5 to 30 min depending on mouse age. The cornea, lens, sclera, and vitreous were excised by limbal incision under a dissecting microscope. For flat mount preparation, retinas and choroids were detached and separated from the optic nerve with fine forceps. Radial incisions were made towards their edges. The flattened retinas were then washed with PBS and processed for β-gal activity assay and immunohistochemistry. For transverse section analyses, the retinas and choroids were not separated, instead they were immersed in 15% sucrose and OCT compound (TissUE-Tek) before being frozen in liquid N2 and cryostat-sectioned at 20 µm. Immunohistochemistry was performed as described ([@b37]).

Xgal staining {#s4c}
-------------

*Msx1^lacZ^* and *Msx2^lacZ^* genes expression was visualized by Xgal staining as described by ([@b28]). After staining, tissues were post-fixed in 4% PFA for 1 h at room temperature, then washed 3 times in PBS before immunohistochemistry.

Immunohistochemistry {#s4d}
--------------------

Retinas were permeabilised with PBS containing 0.2% Triton X-100 and 50 mM NH4Cl for 30 min. Tissues were washed 3 times in PBS then treated for 1 h with blocking buffer (1 mM MgCl2, 1 mM CaCl~2~, 10% goat serum and 0.5% Tween-20 in PBS). The same blocking solution was used for incubation with primary antibodies overnight at 4°C under gentle agitation. Primary antibodies are listed in [Table 1](#t01){ref-type="table"}. The retinas were washed four times for 5 min with 0.1% Tween-20 in PBS, incubated for 1 h with secondary antibodies diluted in blocking buffer. Secondary antibodies (Invitrogen) were Alexa Fluor 488 goat anti-mouse and goat anti-rabbit, Alexa Fluor 568 goat anti-rabbit, Alexa Fluor 647 goat anti-mouse, Alexa Fluor 635 goat anti-rabbit at 1/300 and Alexa Fluor 488 streptavidin at 1/1000. Retinas were washed again three times for 5 min with 0.1% Tween-20 in PBS, followed by incubation with 2.5 µg/ml of Hoechst 33342 (bisBenzimide trihydrochloride, Sigma) in PBS for 15 min to label nuclei. They were finally washed in PBS and two times in water and flat mounted with Dako mounting medium.

###### Primary antibodies used in this study.

![](bio-01-04-376-t01)

Microscopy of retinal and choroid whole-mounts {#s4e}
----------------------------------------------

Whole-mount retinas were primarily observed under a Zeiss Axiophot fluorescence microscope, and a Zeiss Axioplan equipped with an Apotome, and analysed with the Axiovison software (Carl Zeiss, Jena, Germany). Co-localizations were performed with a confocal microscope Zeiss LSM 700 equipped with the Zen software (Carl Zeiss, Jena, Germany). All captured images were assembled using Adobe Photoshop or Adobe Illustrator (Adobe Systems, San Jose, CA, USA). For quantitative analyses, one-way ANOVA was used to compare independent experiments. Comparison between data groups was performed with the non-parametric Dunnett test.
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